You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Ceftriaxone sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for ceftriaxone sodium and what is the scope of freedom to operate?

Ceftriaxone sodium is the generic ingredient in seven branded drugs marketed by Acs Dobfar, Agila Speclts, Aurobindo Pharma Ltd, Bedford, Facta Farma, Fresenius Kabi Usa, Hospira Inc, Lupin, Qilu, Samson Medcl, Sandoz, Sandoz Inc, Teva, Wockhardt, B Braun, Baxter Hlthcare, Anda Repository, Hikma, Hoffmann La Roche, Roche, Astral, Cephazone Pharma, Deva Holding As, Epic Pharma Llc, Hikma Farmaceutica, and Teva Pharms Usa, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for ceftriaxone sodium. Sixteen suppliers are listed for this compound.

Summary for ceftriaxone sodium
US Patents:0
Tradenames:7
Applicants:26
NDAs:42
Drug Master File Entries: 25
Finished Product Suppliers / Packagers: 16
Raw Ingredient (Bulk) Api Vendors: 76
Clinical Trials: 23
Patent Applications: 7,388
What excipients (inactive ingredients) are in ceftriaxone sodium?ceftriaxone sodium excipients list
DailyMed Link:ceftriaxone sodium at DailyMed
Recent Clinical Trials for ceftriaxone sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of DuhokN/A
Muhammad Junaid TahirPhase 3
Ahmad ZiaPhase 3

See all ceftriaxone sodium clinical trials

Pharmacology for ceftriaxone sodium
Medical Subject Heading (MeSH) Categories for ceftriaxone sodium

US Patents and Regulatory Information for ceftriaxone sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc CEFTRIAXONE ceftriaxone sodium INJECTABLE;INJECTION 065231-001 Aug 2, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira Inc CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065230-003 Aug 2, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astral CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 091049-004 Jun 11, 2018 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065169-001 May 9, 2005 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astral CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 091049-003 Jun 11, 2018 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cephazone Pharma CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065294-003 Mar 26, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.